In The News

Vancouver, July 26th, 2024 — Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”), announces that it has received a Notice of Sale Under Mortgage, affecting its property located at 100 Circuit Rider Drive, Napanee, Ontario. The notice

Vancouver, July 24th, 2024 — Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) today announced that John Karagiannidis will be stepping down from the Board of Directors due to personal reasons, effective July 23, 2024. The Chairman

June 20, 2024 5:00 PM EDT | Source: Lophos Holdings Inc. Vancouver, British Columbia–(Newsfile Corp. – June 20, 2024) – Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a

Napanee, Ontario–(Newsfile Corp. – May 15, 2024) – Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”) proudly announces the traditional blessing of its Napanee site, paying homage to the indigenous heritage of its founders and sanctifying the grounds for the cultivation of Lophophora williamsii (peyote) moving forward. The ceremony,

NAPANEE, Ontario, May 06, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is pleased to announce that its wholly-owned subsidiary, Lophos Pharmaceuticals Corp. (“Lophos Pharma”) – a biosciences company specializing in the cultivation, research, and sale of Lophophora williamsii (peyote), announced today that it has entered

NAPANEE, Ontario, May 02, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is pleased to announce the official commencement of its first research protocol under its wholly-owned subsidiary, Lophos Pharmaceuticals Corp. The protocol, centered on the cultivation of Lophophora williamsii (Peyote), marks a significant milestone in

VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”) proudly announces a milestone accomplishment from its subsidiary, Lophos Pharmaceuticals Corp. Specializing in the cultivation, research, and commercialization of peyote, the company has completed the propagation of an additional three thousand (3,000)

VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC) is delighted to announce the successful receipt of building occupancy for its subsidiary, Lophos Pharmaceuticals Corp., in Napanee, Ontario. This milestone achievement follows the dedicated efforts of Carmichael Engineering Ltd., the esteemed HVAC

VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD”), a publicly traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, and Lophos Holdings Inc. (“Lophos”), have entered into a Securities Purchase Agreement (“Agreement”) on April 12,

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company“) is pleased to announce all matters presented for approval at the annual general meeting of the shareholders of the Company held earlier today March 28, 2024 (the “Meeting“) have been approved. A

NAPANEE, Ontario, March 05, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos” or the “Company”) (CSE:MESC) is pleased to announce its subsidiary, Lophos Pharmaceuticals Corp., has selected Carmichael Engineering Ltd., a renowned HVAC engineering and construction firm headquartered in Belleville, ON, to drive the completion of its HVAC project and

NAPANEE, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is thrilled to announce its wholly-owned subsidiary, Lophos Pharmaceuticals Corp., will participate in the upcoming Benzinga Capital Conference, scheduled to take place in Hollywood, Florida, on April 16-17, 2024. Lophos will be showcasing their

NAPANEE, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned subsidiary, Lophos Pharmaceuticals Corp., and proudly announces the finalization of a pioneering research protocol, aimed at identifying the optimal soil conditions for

NAPANEE, Ontario, Feb. 08, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned subsidiary, Lophos Pharmaceuticals Corp. Lophos Pharmaceuticals Corp. proudly announces the finalization of its pioneering procedure for the production of synthetic mescaline. This innovative

NAPANEE, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned subsidiary, Lophos Pharmaceuticals Corp. The subsidiary has achieved a noteworthy milestone in the cultivation and ethical distribution of psychoactive plants and is

NAPANEE, Ontario, Nov. 21, 2023 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos“, or the “Company“) (CSE:MESC) is delighted to share additional information on its wholly-owned subsidiary, Lophos Pharmaceuticals Corp., which has achieved an important milestone by obtaining a significant amendment to its Controlled Substance Dealer’s license by Health Canada for